Guidance documents for colorectal and anal cancer treatment: A systematic quality and reporting assessment.
Marta Maes-CarballoManuel García-GarcíaYolanda Gómez-FandiñoDiego De-Dios-de-SantiagoCarmen Martínez-MartínezAurora Bueno-CavanillasKhalid Saeed KhanPublished in: Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland (2022)
The quality and reporting of colorectal and anal cancer treatment CPGs and CSs were poor. Despite AGREE II and RIGHT inherent methodological limitations, few high-quality guidelines were found. Despite wide variability in scoring different domains, they merit urgent improvement in all areas. It has also been demonstrated that CPGs and CSs should be underpinned by systematic reviews collecting the best available clinical research findings.